Spots Global Cancer Trial Database for Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases
Official Title: A Multicenter, Open-label Study to Determine the Effect of iv. Zoledronic Acid on Pain and Quality of Life in Patients With Bone Metastases With or Without Skeletal Related Events (SRE) Resulting From Breast Cancer and Prostate Cancer
Study ID: NCT00434317
Conditions
Interventions
Study Description
Brief Summary: This study will evaluate the safety, tolerability and efficacy of zoledronic acid administered intravenously every 3-4 weeks in patients with bone metastases from either breast cancer or prostate cancer.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Novartis Investigative Site, Budapest, , Hungary
Novartis Investigative Site, Pecs, , Hungary
Novartis Investigative Site, Szeged, , Hungary
Novartis Investigative Site, Szekesfehervar, , Hungary
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
